Literature DB >> 22215191

Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms.

Humberto Gonçalves Bertão1, Renata Alexandre Ramos da Silva, Rafael José R Padilha, Mônica Camelo Pessôa de Azevedo Albuquerque, Gandhi Rádis-Baptista.   

Abstract

Schistosomiasis is an infectious parasitic disease caused by helminths from the genus Schistosoma; it affects over 200 million people globally and is endemic in 70 countries. In Brazil, 6 million individuals are infected with Schistosoma mansoni. Furthermore, as the prevalence of S. mansoni infections is increasing, approximately 26 million citizens in 19 Brazilian states are at risk for infection. Schistosomiasis disease control involves predominately the administration of a single drug, praziquantel. Although praziquantel exhibits chemotherapeutic efficacy and safety, its massive use in endemic zones, the possibility of the emergence of drug-resistant Schistosoma parasites, and the lack of another efficacious antischistosomal drug demand the discovery of new schistosomicidal compounds. First developed as anti-tumor drug, miltefosine is an alkylphospholipid derivative that exhibits bioactivity against Leishmania and Trypanosoma parasites, free-living protozoa, bacteria, and fungi. With its anti-parasite activity, miltefosine was the first orally administered drug against visceral and cutaneous leishmaniasis approved. Previously, by means of the MTT cytotoxic assay and a DNA fragmentation test, we verified that, at doses of 100 and 200 μM (40 and 80 μg/mL), miltefosine exhibited in vitro schistosomicidal activity against adult S. mansoni worms. Here, we present ultrastructural evidence of rapid, severe miltefosine-induced surface membrane damage in S. mansoni following drug treatment. The number of dead parasites was concentration- and time-dependent following miltefosine treatment. At a miltefosine concentration of 200 μM (∼80 μg/mL), in vitro parasite killing was initiated as early as 3 h post-incubation, and it was maximal after 24 h of treatment. The parasite death was preceded by progressive surface membrane damage, characterized by tegument peeling, spine reduction and erosion, blister formation and rupture, and the emergence of holes. According to our present results, miltefosine is very effective at inducing membrane destruction of S. mansoni with a short onset of pharmacological action.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215191     DOI: 10.1007/s00436-011-2786-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  49 in total

1.  Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni.

Authors:  Juliana Kelle de Andrade Lemoine Neves; Sandra Paula Sarinho Botelho; Cristiane Moutinho Lagos de Melo; Valéria Rêgo Alves Pereira; Maria do Carmo Alves de Lima; Ivan da Rocha Pitta; Mônica Camelo Pessoa de Azevedo Albuquerque; Suely Lins Galdino
Journal:  Parasitol Res       Date:  2010-05-04       Impact factor: 2.289

2.  Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.

Authors:  T Wieder; C E Orfanos; C C Geilen
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

3.  Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity.

Authors:  Priscilla P Luz; Lizandra G Magalhães; Ana Carolina Pereira; Wilson R Cunha; Vanderlei Rodrigues; Marcio L Andrade E Silva
Journal:  Parasitol Res       Date:  2011-07-08       Impact factor: 2.289

4.  The integument of Schistosoma mansoni.

Authors:  J H Smith; E S Reynolds; F Von Lichtenberg
Journal:  Am J Trop Med Hyg       Date:  1969-01       Impact factor: 2.345

5.  Ultrastructure of the tegument of adult Schistosoma mansoni.

Authors:  G P Morris; L T Threadgold
Journal:  J Parasitol       Date:  1968-02       Impact factor: 1.276

6.  Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities.

Authors:  M Rybczynska; M Spitaler; N G Knebel; G Boeck; H Grunicke; J Hofmann
Journal:  Biochem Pharmacol       Date:  2001-09-15       Impact factor: 5.858

Review 7.  Ca2+ signalling, voltage-gated Ca2+ channels and praziquantel in flatworm neuromusculature.

Authors:  R M Greenberg
Journal:  Parasitology       Date:  2005       Impact factor: 3.234

Review 8.  Human schistosomiasis.

Authors:  Bruno Gryseels; Katja Polman; Jan Clerinx; Luc Kestens
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

9.  Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.

Authors:  José M Jiménez-López; Pablo Ríos-Marco; Carmen Marco; Josefa L Segovia; María P Carrasco
Journal:  Lipids Health Dis       Date:  2010-03-25       Impact factor: 3.876

10.  Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro.

Authors:  Sanaa S Botros; Samia William; James R Beadle; Nadejda Valiaeva; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more
  18 in total

1.  Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma mansoni.

Authors:  Sheilla Andrade de Oliveira; Miria de Oliveira Barbosa; Carlos André Laranjeira Miranda Filho; Arsênio Rodrigues Oliveira; Fabiano Amaro de Sousa; Edna de Farias Santiago; Gevanio Bezerra de Oliveira Filho; Paulo André Teixeira de Moraes Gomes; Juliana Maria da Conceição; Fábio André Brayner; Luiz Carlos Alves; Ana Cristina Lima Leite
Journal:  Parasitol Res       Date:  2018-05-07       Impact factor: 2.289

Review 2.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Miltefosine increases lipid and protein dynamics in Leishmania amazonensis membranes at concentrations similar to those needed for cytotoxicity activity.

Authors:  Rodrigo Alves Moreira; Sebastião Antonio Mendanha; Kelly Souza Fernandes; Grazzielle Guimaraes Matos; Lais Alonso; Miriam Leandro Dorta; Antonio Alonso
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.

Authors:  Maha M Eissa; Mervat Z El-Azzouni; Labiba K El-Khordagui; Amany Abdel Bary; Riham M El-Moslemany; Sara A Abdel Salam
Journal:  Parasit Vectors       Date:  2020-09-15       Impact factor: 3.876

5.  Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2013-12-22       Impact factor: 2.289

6.  Biochemical characterization and role of the proteasome in the oxidative stress response of adult Schistosoma mansoni worms.

Authors:  Renato Graciano de Paula; Alice Maria de Magalhães Ornelas; Enyara Rezende Morais; William de Castro Borges; Massimo Natale; Lizandra Guidi Magalhães; Vanderlei Rodrigues
Journal:  Parasitol Res       Date:  2014-05-29       Impact factor: 2.289

7.  Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.

Authors:  Edna de Farias Santiago; Sheilla Andrade de Oliveira; Gevânio Bezerra de Oliveira Filho; Diogo Rodrigo Magalhaes Moreira; Paulo André Teixeira Gomes; Anekécia Lauro da Silva; Andréia Ferreira de Barros; Aline Caroline da Silva; Thiago André Ramos Dos Santos; Valéria Rêgo Alves Pereira; Gabriel Gazzoni Araújo Gonçalves; Fábio André Brayner; Luiz Carlos Alves; Almir Gonçalves Wanderley; Ana Cristina Lima Leite
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

8.  Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.

Authors:  Edward Yepes; Rubén E Varela-M; Julio López-Abán; Jose Rojas-Caraballo; Antonio Muro; Faustino Mollinedo
Journal:  PLoS Negl Trop Dis       Date:  2015-07-20

9.  Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni.

Authors:  Josué de Moraes; Rosimeire N de Oliveira; Jéssica P Costa; Antonio L G Junior; Damião P de Sousa; Rivelilson M Freitas; Silmara M Allegretti; Pedro L S Pinto
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

10.  Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

Authors:  Maha M Eissa; Riham M El-Moslemany; Alyaa A Ramadan; Eglal I Amer; Mervat Z El-Azzouni; Labiba K El-Khordagui
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.